Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation
Authors: Isuru Ranasinghe, Sadia Hossain, Anand Ganesan, Harlan M. Krumholz, Andrew McGavigan
Journal: Annals of Internal Medicine (2020)

Letters21 January 2020Institutional Variation in Quality of Cardiovascular Implantable Electronic Device ImplantationIsuru Ranasinghe, MBChB, MMed(Clin Epi), PhD, Sadia Hossain, PhD, Anand Ganesan, MBBS, PhD, Harlan M. Krumholz, MD, SM, and Andrew McGavigan, MBChB, MDIsuru Ranasinghe, MBChB, MMed(Clin Epi), PhDBasil Hetzel Institute for Translational Research, University of Adelaide, and Central Adelaide Local Health Network, Adelaide, South Australia, Australia (I.R.), Sadia Hossain, PhDBasil Hetzel Institute for Translational Research and University of Adelaide, Adelaide, South Australia, Australia (S.H.), Anand Ganesan, MBBS, PhDFlinders University and Flinders Medical Centre, Adelaide, South Australia, Australia (A.G., A.M.), Harlan M. Krumholz, MD, SMYale–New Haven Hospital, Yale School of Medicine, and Yale University, New Haven, Connecticut (H.M.K.), and Andrew McGavigan, MBChB, MDFlinders University and Flinders Medical Centre, Adelaide, South Australia, Australia (A.G., A.M.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L19-0709 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Dr. Emami and colleagues suggest that our use of administrative data overestimated the risk for CIED complications. However, their conclusion is not supported by our findings or the broader literature.Clinical studies have consistently shown a high rate of CIED complications despite not using administrative data. In Australia and New Zealand, multicenter clinical audits report a 3.9% to 4.6% rate of in-hospital complications. This rate increases to 11.9% (with 7.9% requiring reoperation) when early postdischarge complications are included (1).We defined major complications as those that resulted in death or readmission, required intervention, or prolonged the hospital stay. ...References1. Larsen PD, Kerr AJ, Hood M, et al; ANZACS-QI investigators. Pacemaker use in New Zealand—data from the New Zealand implanted cardiac device registry (ANZACS-QI 15). Heart Lung Circ. 2017;26:235-39. [PMID: 27475261] doi:10.1016/j.hlc.2016.06.1206 CrossrefMedlineGoogle Scholar2. U.S. Food and Drug Administration. What is a serious adverse event? 2016. Accessed at https://www.fda.gov/safety/reporting-serious-problems-fda/what-serious-adverse-event on 10 December 2019. Google Scholar3. Henderson T, Shepheard J, Sundararajan V. Quality of diagnosis and procedure coding in ICD-10 administrative data. Med Care. 2006;44:1011-9. [PMID: 17063133] CrossrefMedlineGoogle Scholar4. Ng J, Andrew P, Muir P, et al. Feasibility and reliability of clinical coding surveillance for the routine monitoring of adverse drug events in New Zealand hospitals. N Z Med J. 2018;131:46-60. [PMID: 30359356] MedlineGoogle Scholar5. Parkash R, Sapp J, Gardner M, et al. Use of administrative data to monitor cardiac implantable electronic device complications. Can J Cardiol. 2019;35:100-3. [PMID: 30595171] doi:10.1016/j.cjca.2018.10.018 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Basil Hetzel Institute for Translational Research, University of Adelaide, and Central Adelaide Local Health Network, Adelaide, South Australia, Australia (I.R.)Basil Hetzel Institute for Translational Research and University of Adelaide, Adelaide, South Australia, Australia (S.H.)Flinders University and Flinders Medical Centre, Adelaide, South Australia, Australia (A.G., A.M.)Yale–New Haven Hospital, Yale School of Medicine, and Yale University, New Haven, Connecticut (H.M.K.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-2810. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoInstitutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation Isuru Ranasinghe , Clementine Labrosciano , Dennis Horton , Anand Ganesan , Jeptha P. Curtis , Harlan M. Krumholz , Andrew McGavigan , Sadia Hossain , Tracy Air , and Saranya Hariharaputhiran Institutional Variation in Quality of Cardiovascular Implantable Electronic Device Implantation Mehrdad Emami , Christopher X. Wong , Samuel Tu , Prashanthan Sanders , and Glenn D. Young Metrics Cited byNontransvenous Cardiovascular Implantable Electronic Device Technology—A Review for the Anesthesiologist 21 January 2020Volume 172, Issue 2Page: 166-167KeywordsAdverse eventsCardiovascular implantable electronic devicesClinical trialsDisclosureFood and Drug AdministrationPacemakersResearch designSerious adverse eventsSpecificity ePublished: 21 January 2020 Issue Published: 21 January 2020 Copyright & PermissionsCopyright © 2020 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...